Search Results - "WALTON, Zandra"
-
1
MYC, Metabolism, and Cancer
Published in Cancer discovery (01-10-2015)“…The MYC oncogene encodes a transcription factor, MYC, whose broad effects make its precise oncogenic role enigmatically elusive. The evidence to date suggests…”
Get more information
Journal Article -
2
Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR
Published in Cell (28-06-2018)“…Recent reports indicate that hypoxia influences the circadian clock through the transcriptional activities of hypoxia-inducible factors (HIFs) at clock genes…”
Get full text
Journal Article -
3
ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation
Published in Cancer cell (13-11-2012)“…Oncogenic Myc alters mitochondrial metabolism, making it dependent on exogenous glutamine (Gln) for cell survival. Accordingly, Gln deprivation selectively…”
Get full text
Journal Article -
4
Fructose-1,6-bisphosphatase opposes renal carcinoma progression
Published in Nature (London) (11-09-2014)“…Fructose-1,6-bisphosphatase is shown to be depleted in clear cell renal cell carcinoma (ccRCC) and inhibits ccRCC progression by antagonizing glycolytic flux…”
Get full text
Journal Article -
5
MYC and metabolism on the path to cancer
Published in Seminars in cell & developmental biology (01-07-2015)“…•The MYC proto-oncogene is commonly deregulated and activated in human cancers.•MYC-dependent metabolism is critical for tumor growth.•MYC alters metabolism…”
Get full text
Journal Article -
6
MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells
Published in Cell metabolism (01-12-2015)“…The MYC oncogene encodes MYC, a transcription factor that binds the genome through sites termed E-boxes (5′-CACGTG-3′), which are identical to the binding…”
Get full text
Journal Article -
7
MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis
Published in PLoS genetics (28-08-2023)“…The molecular circadian clock, which controls rhythmic 24-hour oscillation of genes, proteins, and metabolites in healthy tissues, is disrupted across many…”
Get full text
Journal Article -
8
Current and emerging pharmacotherapies for cytokine release syndrome, neurotoxicity, and hemophagocytic lymphohistiocytosis-like syndrome due to CAR T cell therapy
Published in Expert opinion on pharmacotherapy (11-02-2024)“…Chimeric antigen receptor (CAR) T cells have revolutionized the treatment of multiple hematologic malignancies. Engineered cellular therapies now offer similar…”
Get more information
Journal Article -
9
mTOR Senses Intracellular pH through Lysosome Dispersion from RHEB
Published in BioEssays (01-07-2019)“…Acidity, generated in hypoxia or hypermetabolic states, perturbs homeostasis and is a feature of solid tumors. That acid peripherally disperses lysosomes is a…”
Get full text
Journal Article -
10
Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition
Published in Nature medicine (01-07-2011)“…This report identifies Cdk1's phosphorylation of BRCA1 as an important regulator of BRCA1's DNA repair function. Cdk1 inhibition renders cancer cells sensitive…”
Get full text
Journal Article -
11
Improvement of a giant cell arteritis prediction model
Published in The Lancet. Rheumatology (01-05-2024)Get more information
Journal Article -
12
Inflammatory cytokines in major depressive disorder: A case–control study
Published in Australian & New Zealand Journal of Psychiatry (01-01-2017)“…Introduction: There is mixed evidence in the literature on the role of inflammation in major depressive disorder. Contradictory findings are attributed to lack…”
Get full text
Book Review Journal Article -
13
Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis
Published in The EMBO journal (03-03-2014)“…Metastasis is the leading cause of morbidity for lung cancer patients. Here we demonstrate that murine tumor propagating cells (TPCs) with the markers Sca1 and…”
Get full text
Journal Article -
14
Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors
Published in Cancer cell (13-09-2011)“…Ras-driven tumors are often refractory to conventional therapies. Here we identify a promising targeted therapeutic strategy for two Ras-driven cancers:…”
Get full text
Journal Article -
15
Prospective association between major depressive disorder and leukocyte telomere length over two years
Published in Psychoneuroendocrinology (01-04-2018)“…•A baseline diagnosis of MDD prospectively predicted LTL shortening over two years.•Hierarchical regression analyses found this MDD-telomere effect versus…”
Get full text
Journal Article -
16
Integrative Genomic and Proteomic Analyses Identify Targets for Lkb1-Deficient Metastatic Lung Tumors
Published in Cancer cell (15-06-2010)“…In mice, Lkb1 deletion and activation of Kras G12D results in lung tumors with a high penetrance of lymph node and distant metastases. We analyzed these…”
Get full text
Journal Article -
17
Characterization of the cell of origin for small cell lung cancer
Published in Cell cycle (Georgetown, Tex.) (15-08-2011)“…Small cell lung carcinoma (SCLC) is a neuroendocrine subtype of lung cancer that affects more than 200,000 people worldwide every year with a very high…”
Get full text
Journal Article -
18
Telomere length and telomerase in a well-characterized sample of individuals with major depressive disorder compared to controls
Published in Psychoneuroendocrinology (01-08-2015)“…Highlights • Leukocyte telomere length (LTL) was not associated with depression. • Telomerase activity was higher in men with depression even after adjustment…”
Get full text
Journal Article -
19
Failure to Induce Apoptosis via BCL-2 Family Proteins Underlies Lack of Efficacy of Combined MEK and PI3K Inhibitors for KRAS-Mutant Lung Cancers
Published in Cancer research (Chicago, Ill.) (01-06-2014)“…Although several groups have demonstrated that concomitant use of MEK and phosphoinositide 3-kinase (PI3K) inhibitors (MEKi/PI3Ki) can induce dramatic tumor…”
Get full text
Journal Article -
20
Abstract 2669: Glutaminase alternative splicing controls tumor growth and metabolism
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Cancer cells reprogram their metabolism to meet their energetic and biosynthetic needs, with many cancer cells showing increased aerobic glycolysis…”
Get full text
Journal Article